BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Zhang B, Li C, Cui C, Yue D, Shi B, Zhang Q, Zhang Z, Zhang X, Wang C. Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer. Oncotarget 2017;8:79387-96. [PMID: 29108317 DOI: 10.18632/oncotarget.18154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Hu P, Yan F, Zhang J. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer. Technol Cancer Res Treat 2022;21:153303382210745. [DOI: 10.1177/15330338221074506] [Reference Citation Analysis]
2 Zhou J, Lin Z, Lyu M, Chen N, Liao H, Wang Z, Hao J, Yan C, Liu L. Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol 2020;50:44-57. [PMID: 31735973 DOI: 10.1093/jjco/hyz120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Zhou X, Wu C, Cheng Q. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.Lung. 2020;198:839-846. [PMID: 32683563 DOI: 10.1007/s00408-020-00378-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Mao Q, Xia W, Dong G, Chen S, Wang A, Jin G, Jiang F, Xu L. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery. J Thorac Cardiovasc Surg 2018;155:1784-1792.e3. [PMID: 29554790 DOI: 10.1016/j.jtcvs.2017.11.098] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
5 Xiao W, Liang H, Zhang H, Jia R, Yang Y, Wang Y, Tang P, Yu Z. Ratio between negative and positive lymph nodes is a novel prognostic indicator for patients with esophageal cancer: A Surveillance, Epidemiology and End Results database analysis. Thorac Cancer 2020;11:3490-500. [PMID: 33034409 DOI: 10.1111/1759-7714.13688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kang JY, Park JW, Hwang Y, Hahm JY, Park J, Park KS, Seo SB. The H3K4 methyltransferase SETD1A is required for proliferation of non-small cell lung cancer cells by promoting S-phase progression. Biochem Biophys Res Commun 2021;561:120-7. [PMID: 34023776 DOI: 10.1016/j.bbrc.2021.05.026] [Reference Citation Analysis]
7 Cackowski MM, Gryszko GM, Zbytniewski M, Dziedzic DA, Orłowski TM. Alternative methods of lymph node staging in lung cancer: a narrative review. J Thorac Dis 2020;12:6042-53. [PMID: 33209438 DOI: 10.21037/jtd-20-1997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Bao M, Song Y, Xia J, Li P, Liu Q, Wan Z. miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer. Onco Targets Ther 2018;11:1721-32. [PMID: 29618932 DOI: 10.2147/OTT.S157715] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Zhou X, Wu C, Cheng Q. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer. Lung 2020;198:839-46. [DOI: 10.1007/s00408-020-00378-7] [Reference Citation Analysis]
10 Zhou P, Hu J, Wang X, Wang J, Zhang Y, Wang C. Epidermal growth factor receptor expression affects proliferation and apoptosis in non-small cell lung cancer cells via the extracellular signal-regulated kinase/microRNA 200a signaling pathway. Oncol Lett 2018;15:5201-7. [PMID: 29552158 DOI: 10.3892/ol.2018.7961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]